Charles Hall
Physical Medicine & Rehabilitation · Mobile, ALNPI 1013917459
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Indivior Inc. at 33.6% of the total. Reporting peaked in 2019 at $779 and has fallen 87.8% since, to $95 in 2025.
Across 86 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$533
- Abbott$227
- Collegium Pharmaceutical, Inc.$190
- Amgen$108
- Biodelivery Sciences International, Inc.$99
- Pfizer$74
- plus $354 from 13 others
Across 32 payments — averaging $5154.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endo Pharmaceuticals Inc.$92K
- GRT US Holding, Inc.$54K
- Eli Lilly$14K
- Regeneron$3K
- Pfizer$2K
- Hikma Pharmaceuticals USA$133
- plus $133 from 1 others
What the payments were for
- Consulting fees$80%
- Food & beverage$1,57799%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ETERNA$133
How this compares
$1,585 in reported general payments places this provider in the 75th percentile of 104 physical medicine & rehabilitation providers in Alabama.
See all physical medicine & rehabilitation providers in Alabama →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 88 | $15,392 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Mobile
- Edward SchnitzerMobile$4K
- Ankit GulatiMobile$4K
- Matthew HasleyMobile$3K
- Ashley SteffensMobile$1K
- Don McCormickBirmingham$22K
- Bradly GoodmanBirmingham$15K
- Nelson Santos AgostoBirmingham$14K
- John PantuoscoBirmingham$12K
- Ross LumsdenBirmingham$11K
- Michael RosemoreBessemer$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.